- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01615068
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
July 12, 2018 updated by: Genentech, Inc.
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients With HER2 Positive (HER2+) Metastatic Breast Cancer (SystHERs Registry (Systemic Therapies for HER2+ Metastatic Breast Cancer Study)).
This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).
Eligible patients will have an initial metastatic breast cancer diagnosis that has not been previously treated with systemic therapy; patients may be enrolled up to 6 months after the diagnosis.
Data will be collected for up to 8 years.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
1007
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- St. Vincent'S Hospital; Birmingham Hematology Oncology Associates, Llc
-
Mobile, Alabama, United States, 36604
- University of South Alabama; Mitchell Cancer Institute
-
-
Arizona
-
Sedona, Arizona, United States, 86336
- Arizona Oncology Associates, PC - NAHOA
-
Tucson, Arizona, United States, 85704
- Arizona Oncology
-
-
Arkansas
-
Hot Springs, Arkansas, United States, 71913
- Genesis Cancer Center
-
Jonesboro, Arkansas, United States, 72401
- NEA Baptist Clinic
-
Little Rock, Arkansas, United States, 72205
- Hematology Oncology Services of Arkansas
-
Rogers, Arkansas, United States, 72758
- Highlands Oncology Group
-
-
California
-
Burbank, California, United States, 91505
- East Valley Hem/Onc Med Group; Metropolitan Hem Onc.
-
Campbell, California, United States, 95008
- South Bay Oncology Hematology Partners
-
Encinitas, California, United States, 92008
- California Cancer Associates for Research & Excellence, Inc.
-
Fountain Valley, California, United States, 92708-7510
- ROBERT A. MOSS, M.D., F.A.C.P., Inc
-
Fresno, California, United States, 93720
- Cancer Care Associates
-
Fresno, California, United States, 93710
- California Oncology of the Central Valley
-
Fullerton, California, United States, 92835
- St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr
-
Los Angeles, California, United States, 90033
- University of Southern California
-
Los Angeles, California, United States, 90095
- UCLA School of Medicine
-
Palm Springs, California, United States, 92262
- Comprehensive Cancer Care
-
San Francisco, California, United States, 94115
- Univ of Calif, San Francisco; Breast Cancer Center
-
San Luis Obispo, California, United States, 93401
- Coastal Integrative Cancer Care
-
Santa Maria, California, United States, 93454
- Central Coast Medical Oncology
-
Santa Rosa, California, United States, 95403
- Sutter Pacific Medical Foundation
-
-
Colorado
-
Denver, Colorado, United States, 80220
- Rocky Mountain Cancer Center - Denver
-
Denver, Colorado, United States, 80218
- Kaiser Permanente of Colorado
-
Littleton, Colorado, United States, 80122
- Mile High Oncology
-
-
Connecticut
-
Middletown, Connecticut, United States, 06457
- Connecticut Oncology Group
-
New Haven, Connecticut, United States, 06520
- Yale Cancer Center
-
Stamford, Connecticut, United States, 06902
- Hematology Oncology P.C.
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- MedStar Washington Hosp Center
-
-
Florida
-
Boca Raton, Florida, United States, 33428
- Lynn Cancer Institute - West
-
Deerfield Beach, Florida, United States, 33442
- University of Miami; Dept Sylvester Cancer Center
-
Fort Myers, Florida, United States, 33901-8101
- Florida Cancer Specialists - Fort Myers (New Hampshire Ct)
-
Hollywood, Florida, United States, 33021
- Memorial Cancer Institute
-
Jacksonville, Florida, United States, 32207
- Baptist - MD Anderson Cancer Center
-
Jacksonville, Florida, United States, 32256
- Florida Oncology Associates
-
Lakeland, Florida, United States, 33804-1057
- Lakeland Regional Cancer Center
-
Orlando, Florida, United States, 32806
- MD Anderson Cancer Center Orlando
-
Plantation, Florida, United States, 33324
- Florida Cancer Research Institute
-
Saint Petersburg, Florida, United States, 33705
- Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building)
-
Titusville, Florida, United States, 32795
- Space Coast Medical Associates
-
-
Georgia
-
Atlanta, Georgia, United States, 30318
- Peachtree Hematology & Oncology Consultants, Pc
-
Marietta, Georgia, United States, 30060
- Northwest Georgia Oncology Centers PC - Marietta
-
Savannah, Georgia, United States, 31405
- Summit Cancer Care PC
-
-
Idaho
-
Post Falls, Idaho, United States, 83854
- Kootenai Cancer Center
-
-
Illinois
-
Alton, Illinois, United States, 62002
- Alton Memorial Hospital; Outpatient Clinic and Infusion Center
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Normal, Illinois, United States, 61761
- Mid-Illinois Hematology
-
Park Ridge, Illinois, United States, 60068
- Oncology Specialists, S.C.
-
Skokie, Illinois, United States, 60076
- Orchard Healthcare Research Inc.
-
Urbana, Illinois, United States, 61801
- Carle Cancer Center
-
-
Indiana
-
Evansville, Indiana, United States, 47714
- Oncology Hematology Assoc
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
Mason City, Iowa, United States, 50401
- Mercy Medical Ctr-North Iowa ; Mercy Cancer Center
-
-
Kansas
-
Wichita, Kansas, United States, 67214-3728
- Cancer Center of Kansas
-
-
Kentucky
-
Louisville, Kentucky, United States, 40207
- Baptist Hospital East
-
Louisville, Kentucky, United States, 40202
- James Graham Brown Cancer Center, University of Louisville
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70809
- Medical Oncology LLC
-
Baton Rouge, Louisiana, United States, 70809
- Mary Bird Perkins Cancer Ctr
-
Lafayette, Louisiana, United States, 70503-2616
- Lafayette General Medical Center
-
-
Maine
-
Portland, Maine, United States, 04102
- Mercy Oncology / Hematology Center; Oncology
-
-
Maryland
-
Cumberland, Maryland, United States, 21502
- Western Maryland Health Sys
-
Rockville, Maryland, United States, 20850
- Associates in Oncology/Hematology P.C.
-
Silver Spring, Maryland, United States, 20902
- Capitol Hematology & Oncology
-
Towson, Maryland, United States, 21204
- St. Joseph Medical Center
-
Westminster, Maryland, United States, 21157
- Carroll County Cancer Center
-
-
Massachusetts
-
Pittsfield, Massachusetts, United States, 01201
- Berkshire Hematology, Oncology Pc
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- Cancer & Hematology Centers of Western Michigan
-
Kalamazoo, Michigan, United States, 49007
- West Michigan Cancer Center
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Southdale Cancer Clinic U of M Medical Center, Fairview- Edina
-
Minneapolis, Minnesota, United States, 55407
- Minnesota Oncology Hematology, PA
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Clinic Cancer Center
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Jackson Oncology Associates, PLLC
-
-
Missouri
-
Jefferson City, Missouri, United States, 65109
- Jefferson City Medical Group
-
Kansas City, Missouri, United States, 64132
- Research Medical Center; Pharmacy
-
Saint Louis, Missouri, United States, 63141
- St. John'S Mercy Medical Center; David C. Pratt Cancer Center
-
Saint Louis, Missouri, United States, 63136
- Christian Hospital; Outpatient Cancer and Infusion Center
-
-
Montana
-
Billings, Montana, United States, 59101
- Billings Clinic Research Center
-
Missoula, Montana, United States, 59802
- Montana Cancer Specialists
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- Southeast Nebraska Cancer Center;; Southeast Nebraska Hematology and Oncology
-
Omaha, Nebraska, United States, 68106
- Cancer Alliance of Nebraska
-
-
Nevada
-
Las Vegas, Nevada, United States, 89128
- Comprehensive Cancer Centers of Nevada
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center; Gastroenterology Section
-
Portsmouth, New Hampshire, United States, 03801
- Portsmouth Regional Hospital; Hem/Onc Clinic
-
-
New Jersey
-
Berkeley Heights, New Jersey, United States, 07922
- Summit Medical Group
-
Denville, New Jersey, United States, 07834
- Onc & Hematology Specialists
-
Hackensack, New Jersey, United States, 07601
- Hackensack University Medical Center
-
Morristown, New Jersey, United States, 07960
- Hematology Oncology Associates; Carol G. Simon Ctr
-
Paramus, New Jersey, United States, 07652
- Luckow Pavillion, Valley Hosp; Office of Clinical Trials
-
-
New York
-
Cooperstown, New York, United States, 13326
- The Mary Imogene Bassett Hospi
-
East Setauket, New York, United States, 11733
- North Shore Hem Onc Associates
-
Jamaica, New York, United States, 11432
- Queens Hospital Center
-
New York, New York, United States, 10032
- Herbert Irving Comprehensive Cancer Center; Herbert Irving Pavillion
-
New York, New York, United States, 10011
- Beth Israel Comprehensive Cancer Center Pharmacy
-
-
North Carolina
-
Asheville, North Carolina, United States, 28806
- Hope A Women's Cancer Center
-
Gastonia, North Carolina, United States, 28054
- Gaston Hematology/Oncology
-
Greensboro, North Carolina, United States, 27403
- Cone Health Cancer Center
-
Lumberton, North Carolina, United States, 28358
- Southeastern Regional Medical Center
-
Pinehurst, North Carolina, United States, 28374
- First Health of the Carolinas
-
-
Ohio
-
Cleveland, Ohio, United States, 44109
- Metro Health Medical Center
-
Columbus, Ohio, United States, 43219
- Mid Ohio Onc Hematology Inc
-
Middletown, Ohio, United States, 45042
- Signal Point Clinical; Research Center, LLC
-
Sylvania, Ohio, United States, 43560
- Flower Memorial Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Mercy Clinic Oklahoma Communties, Inc
-
Tulsa, Oklahoma, United States, 74104
- Cancer Care Assoc-15th St
-
-
Oregon
-
Portland, Oregon, United States, 97231
- Providence Cancer Center
-
-
Pennsylvania
-
Dunmore, Pennsylvania, United States, 18512
- Hematology & Oncology Assoc; North Eastern Pennsylvania
-
Lancaster, Pennsylvania, United States, 17605
- Lancaster Cancer Center, Ltd.
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, United States, 15213
- Univ of Pittsburgh Sch of Med; Magee-Womens Hospital
-
Pittsburgh, Pennsylvania, United States, 15212
- Allegheny General Hospital; Transplantation Services
-
Sayre, Pennsylvania, United States, 18840
- Guthrie Clinic
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Charleston Hematology Oncology
-
Charleston, South Carolina, United States, 29425
- Medical Univ Of South Carolina
-
Columbia, South Carolina, United States, 29210
- South Carolina Oncology Associates - SCRI
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Chattanooga Oncology and Hematology Associates, PC
-
Kingsport, Tennessee, United States, 37660
- Kingsport Hematology Oncology Associates
-
Knoxville, Tennessee, United States, 37909
- Center for Biomedical Research LLC
-
Nashville, Tennessee, United States, 37203
- Sarah Cannon Research Inst.
-
Nashville, Tennessee, United States, 37203
- Boston Baskin Cancer Foundation
-
-
Texas
-
Abilene, Texas, United States, 79601-2301
- Hendrick Cancer Center
-
Bedford, Texas, United States, 76022
- Texas Oncology
-
Bryan, Texas, United States, 77802
- St. Joseph Regional Cancer Ct
-
Dallas, Texas, United States, 75246
- Texas Oncology-Baylor Sammons Cancer Center
-
El Paso, Texas, United States, 79915
- Texas Oncology- El Paso Cancer Treatment Center Gateway
-
Fort Worth, Texas, United States, 76104
- Texas Oncology, P.A. - Fort Worth
-
Houston, Texas, United States, 77024
- Texas Oncology - Houston (Gessner)
-
McAllen, Texas, United States, 78503
- Texas Oncology, P.A. - McAllen; South Texas Cancer Center-McAllen
-
Paris, Texas, United States, 75460
- Texas Oncology - Paris
-
Tyler, Texas, United States, 75701
- Tyler Hematololgy Oncology, PA
-
Waco, Texas, United States, 76712
- Texas Oncology, PA
-
Webster, Texas, United States, 77598-4420
- Texas Oncology, P.A.; Duke Slayton Cancer Center
-
-
Utah
-
Ogden, Utah, United States, 84403
- Northern Utah Associates
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Institute; Oncology
-
-
Virginia
-
Lynchburg, Virginia, United States, 24501
- Lynchburg Hem Onc Clinic Inc
-
Newport News, Virginia, United States, 23601
- Peninsula Cancer Institute
-
Richmond, Virginia, United States, 23226
- Virginia Cancer Institute
-
Winchester, Virginia, United States, 22601
- Shenandoah Oncology Associates
-
-
Washington
-
Seattle, Washington, United States, 98101
- Virginia Mason Medical Center
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26056
- West Virginia University Hospitals Inc
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin
-
Milwaukee, Wisconsin, United States, 53211
- Columbia Saint Mary's; Medical Oncology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with HER2 positive (HER2+) metastatic breast cancer
Description
Inclusion Criteria:
- Adult patients, >/=18 years of age
- Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
- Availability of cancer-specific historical data points in the patient's medical records
Exclusion Criteria:
- Any inability to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Cohort
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Distribution of patients receiving unique treatment regimen/sequence of treatment regimens
Time Frame: Up to 8 years
|
Up to 8 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Progression-free survival (PFS)
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Overall survival (OS)
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Post-progression survival (PPS)
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Time-to-treatment failure (TTF)
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Response rate (RR)
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Safety: Incidence of adverse events
Time Frame: Up to 8 years
|
Up to 8 years
|
|
Patient-reported outcome assessment (PRO)
Time Frame: Up to 8 years
|
Up to 8 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tripathy D, Brufsky A, Cobleigh M, Jahanzeb M, Kaufman PA, Mason G, O'Shaughnessy J, Rugo HS, Swain SM, Yardley DA, Chu L, Li H, Antao V, Hurvitz SA. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry. Oncologist. 2020 Feb;25(2):e214-e222. doi: 10.1634/theoncologist.2019-0446. Epub 2019 Oct 14.
- Cobleigh M, Yardley DA, Brufsky AM, Rugo HS, Swain SM, Kaufman PA, Tripathy D, Hurvitz SA, O'Shaughnessy J, Mason G, Antao V, Li H, Chu L, Jahanzeb M. Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs. Clin Cancer Res. 2020 Mar 1;26(5):1105-1113. doi: 10.1158/1078-0432.CCR-19-2350. Epub 2019 Nov 26.
- Hurvitz SA, O'Shaughnessy J, Mason G, Yardley DA, Jahanzeb M, Brufsky A, Rugo HS, Swain SM, Kaufman PA, Tripathy D, Chu L, Li H, Antao V, Cobleigh M. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs. Clin Cancer Res. 2019 Apr 15;25(8):2433-2441. doi: 10.1158/1078-0432.CCR-18-2366. Epub 2018 Dec 28.
- Tripathy D, Rugo HS, Kaufman PA, Swain S, O'Shaughnessy J, Jahanzeb M, Mason G, Beattie M, Yoo B, Lai C, Masaquel A, Hurvitz S. The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. BMC Cancer. 2014 May 2;14:307. doi: 10.1186/1471-2407-14-307.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2012
Primary Completion (Actual)
November 16, 2017
Study Completion (Actual)
November 16, 2017
Study Registration Dates
First Submitted
June 6, 2012
First Submitted That Met QC Criteria
June 7, 2012
First Posted (Estimate)
June 8, 2012
Study Record Updates
Last Update Posted (Actual)
July 16, 2018
Last Update Submitted That Met QC Criteria
July 12, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ML28257
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States